Phase II Study of Perifosine for Patients With Metastatic Carcinoma of the Kidney Who Have Progressed on a VEGF Receptor Inhibitor.
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Perifosine (Primary)
- Indications Renal cancer
- Focus Therapeutic Use
- Sponsors AEterna Zentaris Inc
- 18 Jun 2012 Data from this trial has been published in the June 2012 issue of Cancer, according to an AEterna Zentaris media release.
- 16 Oct 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
- 16 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.